Park, J., Karnati, H., Rustgi, S. D., Hur, C., Kong, X.-F., & Kastrinos, F. (2025). Impact of population screening for Lynch syndrome insights from the All of Us data. Nature Communications, 16(1). https://doi.org/10.1038/s41467-024-52562-5

Balasubramanian, R., Kizhatil, K., Li, T., Tolman, N., Bhandari, A., Clark, G., Bupp-Chickering, V., Kelly, R. A., Zhou, S., Peregrin, J., Simón, M., Montgomery, C., Stamer, W. D., Qian, J., & John, S. W. (2024). Transcriptomic profiling of Schlemm’s canal cells reveals a lymphatic-biased identity and three major cell states. ELife, 13. CLOCKSS. https://doi.org/10.7554/elife.96459.3

Connelly, C. F., Towne, W. S., Desai, N., Smithgall, M. C., Cimic, A., & Baskota, S. U. (2024). Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2024.08.130

Karloski, E., Dudley, B., Diergaarde, B., Blanco, A., Everett, J. N., Levinson, E., Rangarajan, T., Stanich, P. P., Childers, K., Brown, S., Drogan, C., Cavestro, G. M., Gordon, K., Singh, A., Simeone, D. M., Reich, H., Kastrinos, F., Zakalik, D., Hampel, H., … Brand, R. E. (2024). The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Cancer. Portico. https://doi.org/10.1002/cncr.35383

Yuan, S., Leffler, D., Lebwohl, B., Green, P. H. R., Sun, J., Carlsson, S., Larsson, S. C., & Ludvigsson, J. F. (2024). Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study. Diabetologia. https://doi.org/10.1007/s00125-024-06175-8

Balasubramanian, R., Kizhatil, K., Li, T., Tolman, N., Bhandari, A., Clark, G., Bupp-Chickering, V., Kelly, R. A., Zhou, S., Peregrin, J., Simón, M., Montgomery, C., Stamer, W. D., Qian, J., & John, S. W. (2024). Transcriptomic profiling of Schlemm’s canal cells reveals a lymphatic-biased identity and three major cell states. ELife, 13. CLOCKSS. https://doi.org/10.7554/elife.96459

Church, J. (2024). Being a Colorectal Geneticist. Diseases of the Colon & Rectum, 67(6), 743–747. https://doi.org/10.1097/dcr.0000000000003306

Yuan, S., Jiang, F., Chen, J., Lebwohl, B., Green, P. H. R., Leffler, D., Larsson, S. C., Li, X., & Ludvigsson, J. F. (2024). Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease. EBioMedicine, 101, 105033. https://doi.org/10.1016/j.ebiom.2024.105033

Dabbs, D. J., Chiriboga, L. A., Jasani, B., Kinloch, M. A., Miller, K. D., Nielsen, S., Szabolcs, M. J., Torlakovic, E., Bogen, S., Parry, S., & ‘t Hart, N. A. (2023). In Support of Magnani and Taylor. Archives of Pathology & Laboratory Medicine, 148(1), 11–11. https://doi.org/10.5858/arpa.2023-0446-le

Chatila, W. K., Walch, H., Hechtman, J. F., Moyer, S. M., Sgambati, V., Faleck, D. M., Srivastava, A., Tang, L., Benhamida, J., Ismailgeci, D., Campos, C., Wu, F., Chang, Q., Vakiani, E., de Stanchina, E., Weiser, M. R., Widmar, M., Yantiss, R. K., Shah, M. A., … Yaeger, R. (2023). Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nature Communications, 14(1). https://doi.org/10.1038/s41467-022-35592-9

Aziz, Z., Wagner, S., Agyekum, A., Pumpalova, Y. S., Prest, M., Lim, F., Rustgi, S., Kastrinos, F., Grady, W. M., & Hur, C. (2023). Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened. JAMA Network Open, 6(11), e2343392. https://doi.org/10.1001/jamanetworkopen.2023.43392

Malick, A., Lebwohl, B., Green, P. H. R., Lagana, S., & Krishnareddy, S. (2023). S3933 Development of Celiac Disease After Immunotherapy for Psoriasis, Breast Cancer, and Renal Cell Carcinoma: A Case Series. American Journal of Gastroenterology, 118(10S), S2506–S2507. https://doi.org/10.14309/01.ajg.0000965372.95691.4d

Yoon, J. Y., Leven, E., Hur, C., Burke, C. A., & Lucas, A. (2023). S1861 Optimizing Surveillance Strategies for Gastric Cancer in Lynch Syndrome: A Cost-Effectiveness Analysis. American Journal of Gastroenterology, 118(10S), S1382–S1383. https://doi.org/10.14309/01.ajg.0000957084.40895.ff

Diggs, A., Dioun, S., Chen, L., St. Clair, C., de Meritens, A. B., Hou, J., Khoury-Collado, F., & Wright, J. (2023). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy (2204). Gynecologic Oncology, 176, S259. https://doi.org/10.1016/j.ygyno.2023.06.324

Koehne de Gonzalez, A., & del Portillo, A. (2023). P754 Beyond Paneth cell metaplasia: Small intestinal metaplasia of the sigmoid colon in patients with Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 17(Supplement_1), i885–i886. https://doi.org/10.1093/ecco-jcc/jjac190.0884

Chapman-Fredricks, J. R., Thakkar, D., Alderuccio, J. P., Naresh, K. N., Ondrejka, S. L., Hsi, E. D., Xu, M. L., Paulson, N., Koff, J. L., Jaye, D. L., Cohen, J. B., Ortved Gang, A., Leeman-Neill, R. J., Dave, T., Happ, L., Love, C., Zandi, S., Naushad, H., Mason, E. F., … Lossos, I. S. (2022). Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site. Blood, 140(Supplement 1), 6378–6380. https://doi.org/10.1182/blood-2022-165616

Koff, J. L., Kositsky, R., Jaye, D. L., Churnetski, M. C., Baird, K., O’Leary, C. B., Flowers, C. R., Leppa, S., Karjalainen-Lindsberg, M.-L., Li, S., Xu, J., Pedersen, M. Ø., Gang, A. O., Naresh, K. N., Leeman-Neill, R. J., Au Yeung, K. H. R., Qureishi, H. N., Iqbal, J., Chapman-Fredricks, J. R., … Cohen, J. B. (2022). Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma. Blood, 140(Supplement 1), 3500–3503. https://doi.org/10.1182/blood-2022-168002

Molina, J. C., Chinnabhandar, V., Fabrizio, V. A., Kunicki, M., Pacenta, H., Rossoff, J., Stefanski, H. E., Talano, J., Moskop, A., Verneris, M. R., Myers, G. D., Karras, N., Baggott, C., Qayed, M., Hermiston, M. L., Satwani, P., Krupski, C., Keating, A. K., Baumeister, S. H. C., … Smith, S. M. (2022). Standard Cytogenetic Risk Stratification Is Not Predictive of CD19 CAR Outcomes and Impact of Disease Burden Varies between Cytogenetic Risk Groups. Blood, 140(Supplement 1), 10386–10388. https://doi.org/10.1182/blood-2022-165951

Castro, M., Iwamoto, F., Ahluwalia, M., Usmani, S., Kumar, A., Kapoor, S., Suseela, R. P., Kulkarni, S., Mohanty, J., Shyamasundar, V., Ghosh, A., Prasad, N., Patil, M., Choudhury, S. R., Chauhan, J., Sauban, M., Joseph, V., Kumari, P., Mitra, U., … Basu, S. (2022). EPCO-06. THE IMPACT OF MISMATCH REPAIR DEFICIENCY (MMRD) ON SURVIVAL OF TEMOZOLOMIDE (TMZ)-TREATED PATIENTS WITH MGMT METHYLATED (M-MGMT) GLIOBLASTOMA (GBM): A CELLWORKS COMPUTATIONAL BIOSIMULATION PILOT STUDY. Neuro-Oncology, 24(Supplement_7), vii116–vii117. https://doi.org/10.1093/neuonc/noac209.441

Trivedi, M. S., Arber, N., Friedman, E., Garber, J. E., Holcomb, K., Horowitz, N. S., Wright, J. D., Lee, J. J., Vornik, L. A., Abutaseh, S., Castile, T., Sauter, E. R., Dimond, E., Heckman-Stoddard, B. M., House, M., Samimi, G., Brown, P. H., & Crew, K. D. (2022). Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer Prevention Research, 15(11), 721–726. https://doi.org/10.1158/1940-6207.capr-22-0051

Canto, L. M., da Silva, J. M., Castelo-Branco, P. V., da Silva, I. M., Nogueira, L., Fonseca-Alves, C. E., Khayat, A., Birbrair, A., & Pereira, S. R. (2022). Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients. Cancers, 14(14), 3514. https://doi.org/10.3390/cancers14143514

Myer, P. A., Kim, H., Blümel, A. M., Finnegan, E., Kel, A., Thompson, T. V., Greally, J. M., Prehn, J. HM., O’Connor, D. P., Friedman, R. A., Floratos, A., & Das, S. (2022). Master Transcription Regulators and Transcription Factors Regulate Immune-Associated Differences Between Patients of African and European Ancestry With Colorectal Cancer. Gastro Hep Advances, 1(3), 328–341. https://doi.org/10.1016/j.gastha.2022.01.004

Aguiar, T., Teixeira, A., Scliar, M. O., Sobral de Barros, J., Lemes, R. B., Souza, S., Tolezano, G., Santos, F., Tojal, I., Cypriano, M., Caminada de Toledo, S. R., Valadares, E., Borges Pinto, R., Pinto Artigalas, O. A., Caetano de Aguirre Neto, J., Novak, E., Cristofani, L. M., Miura Sugayama, S. M., Odone, V., … Krepischi, A. (2022). Unraveling the Genetic Architecture of Hepatoblastoma Risk: Birth Defects and Increased Burden of Germline Damaging Variants in Gastrointestinal/Renal Cancer Predisposition and DNA Repair Genes. Frontiers in Genetics, 13. https://doi.org/10.3389/fgene.2022.858396

Das, A., Sudhaman, S., Morgenstern, D., Coblentz, A., Chung, J., Stone, S. C., Alsafwani, N., Liu, Z. A., Karsaneh, O. A. A., Soleimani, S., Ladany, H., Chen, D., Zatzman, M., Cabric, V., Nobre, L., Bianchi, V., Edwards, M., Sambira Nahum, L. C., Ercan, A. B., … Tabori, U. (2022). Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nature Medicine, 28(1), 125–135. https://doi.org/10.1038/s41591-021-01581-6